Literature DB >> 23993239

Pathophysiology of thoracic aortic aneurysm (TAA): is it not one uniform aorta? Role of embryologic origin.

Jean Marie Ruddy1, Jeffery A Jones, John S Ikonomidis.   

Abstract

Thoracic aortic aneurysm (TAA) is a clinically silent and potentially fatal disease whose pathophysiology is poorly understood. Application of data derived from animal models and human tissue analysis of abdominal aortic aneurysms may prove misleading given current evidence of structural and biochemical aortic heterogeneity above and below the diaphragm. Genetic predisposition is more common in TAA and includes multi-faceted syndromes such as Marfan, Loeys-Dietz, and type IV Ehlers-Danlos as well as autosomal-dominant familial patterns of inheritance. Investigation into the consequences of these known mutations has provided insight into the cell signaling cascades leading to degenerative remodeling of the aortic medial extracellular matrix (ECM) with TGF-β playing a major role. Targeted research into modifying the upstream regulation or downstream effects of the TGF-β1 pathway may provide opportunities for intervention to attenuate TAA progression.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  AAA; AT1; AngII; ECM; ERK; Extracellular matrix remodeling; MMP; Matrix metalloproteinases; TAA; TGF-β; TGF-βR1 & 2; Thoracic Aortic Aneurysm; Transforming growth factor-beta; VSMC; abdominal aortic aneurysm; angiotensin II; angiotensin receptor 1; extracellular matrix; extracellular signal-regulated kinase; matrix metalloproteinase; t-PA; thoracic aortic aneurysm; tissue plasminogen activator; transforming growth factor beta; transforming growth factor beta receptor 1 & 2; vascular smooth muscle cell

Mesh:

Substances:

Year:  2013        PMID: 23993239      PMCID: PMC3759819          DOI: 10.1016/j.pcad.2013.04.002

Source DB:  PubMed          Journal:  Prog Cardiovasc Dis        ISSN: 0033-0620            Impact factor:   8.194


  56 in total

Review 1.  Recent progress towards a molecular understanding of Marfan syndrome.

Authors:  Harry C Dietz; Bart Loeys; Luca Carta; Francesco Ramirez
Journal:  Am J Med Genet C Semin Med Genet       Date:  2005-11-15       Impact factor: 3.908

2.  Cell-specificity of transforming growth factor-beta response is dictated by receptor bioavailability.

Authors:  Magdalena I Suszko; Teresa K Woodruff
Journal:  J Mol Endocrinol       Date:  2006-06       Impact factor: 5.098

3.  Spatiotemporal expression and localization of matrix metalloproteinas-9 in a murine model of thoracic aortic aneurysm.

Authors:  Jeffrey A Jones; John R Barbour; Abigail S Lowry; Shenikqua Bouges; Christy Beck; David M McClister; Rupak Mukherjee; John S Ikonomidis
Journal:  J Vasc Surg       Date:  2006-12       Impact factor: 4.268

4.  Familial thoracic aortic aneurysms and dissections--incidence, modes of inheritance, and phenotypic patterns.

Authors:  Gonzalo Albornoz; Michael A Coady; Michele Roberts; Ryan R Davies; Maryann Tranquilli; John A Rizzo; John A Elefteriades
Journal:  Ann Thorac Surg       Date:  2006-10       Impact factor: 4.330

5.  Aneurysm syndromes caused by mutations in the TGF-beta receptor.

Authors:  Bart L Loeys; Ulrike Schwarze; Tammy Holm; Bert L Callewaert; George H Thomas; Hariyadarshi Pannu; Julie F De Backer; Gretchen L Oswald; Sofie Symoens; Sylvie Manouvrier; Amy E Roberts; Francesca Faravelli; M Alba Greco; Reed E Pyeritz; Dianna M Milewicz; Paul J Coucke; Duke E Cameron; Alan C Braverman; Peter H Byers; Anne M De Paepe; Harry C Dietz
Journal:  N Engl J Med       Date:  2006-08-24       Impact factor: 91.245

6.  Losartan, an AT1 antagonist, prevents aortic aneurysm in a mouse model of Marfan syndrome.

Authors:  Jennifer P Habashi; Daniel P Judge; Tammy M Holm; Ronald D Cohn; Bart L Loeys; Timothy K Cooper; Loretha Myers; Erin C Klein; Guosheng Liu; Carla Calvi; Megan Podowski; Enid R Neptune; Marc K Halushka; Djahida Bedja; Kathleen Gabrielson; Daniel B Rifkin; Luca Carta; Francesco Ramirez; David L Huso; Harry C Dietz
Journal:  Science       Date:  2006-04-07       Impact factor: 47.728

7.  Mutations in myosin heavy chain 11 cause a syndrome associating thoracic aortic aneurysm/aortic dissection and patent ductus arteriosus.

Authors:  Limin Zhu; Roger Vranckx; Philippe Khau Van Kien; Alain Lalande; Nicolas Boisset; Flavie Mathieu; Mark Wegman; Luke Glancy; Jean-Marie Gasc; François Brunotte; Patrick Bruneval; Jean-Eric Wolf; Jean-Baptiste Michel; Xavier Jeunemaitre
Journal:  Nat Genet       Date:  2006-01-29       Impact factor: 38.330

8.  Thrombospondin 1 mediates angiotensin II induction of TGF-beta activation by cardiac and renal cells under both high and low glucose conditions.

Authors:  Yong Zhou; Maria H Poczatek; Kathleen H Berecek; Joanne E Murphy-Ullrich
Journal:  Biochem Biophys Res Commun       Date:  2005-11-18       Impact factor: 3.575

9.  Transforming growth factor-beta1 induces tissue inhibitor of metalloproteinase-1 expression via activation of extracellular signal-regulated kinase and Sp1 in human fibrosarcoma cells.

Authors:  Hee-Jin Kwak; Myung-Jin Park; Hyeyoung Cho; Chang-Min Park; Sang-Ik Moon; Hyung-Chan Lee; In-Chul Park; Mi-Suk Kim; Chang Hun Rhee; Seok-Il Hong
Journal:  Mol Cancer Res       Date:  2006-03       Impact factor: 5.852

10.  Fibrillin-1 regulates the bioavailability of TGFbeta1.

Authors:  Shazia S Chaudhry; Stuart A Cain; Amanda Morgan; Sarah L Dallas; C Adrian Shuttleworth; Cay M Kielty
Journal:  J Cell Biol       Date:  2007-01-22       Impact factor: 10.539

View more
  27 in total

Review 1.  Understanding the pathogenesis of abdominal aortic aneurysms.

Authors:  Helena Kuivaniemi; Evan J Ryer; James R Elmore; Gerard Tromp
Journal:  Expert Rev Cardiovasc Ther       Date:  2015

2.  Vessel wall morphology is equivalent for different artery types and localizations of advanced human aneurysms.

Authors:  Albert Busch; Caroline Grimm; Elena Hartmann; Valentina Paloschi; Ralph Kickuth; Mariette Lengquist; Christoph Otto; Per Eriksson; Richard Kellersmann; Udo Lorenz; Lars Maegdefessel
Journal:  Histochem Cell Biol       Date:  2017-05-06       Impact factor: 4.304

3.  Differential ascending and descending aortic mechanics parallel aneurysmal propensity in a mouse model of Marfan syndrome.

Authors:  C Bellini; A Korneva; L Zilberberg; F Ramirez; D B Rifkin; J D Humphrey
Journal:  J Biomech       Date:  2015-12-22       Impact factor: 2.712

Review 4.  Emergence of molecular imaging of aortic aneurysm: implications for risk stratification and management.

Authors:  Reza Golestani; Mehran M Sadeghi
Journal:  J Nucl Cardiol       Date:  2014-01-01       Impact factor: 5.952

5.  Pulse wave velocity involving proximal portions of the aorta correlates with the degree of aortic dilatation at the sinuses of valsalva in ascending thoracic aortic aneurysms.

Authors:  Simon W Rabkin; Kenneth K Chan; Bryan Chow; Michael T Janusz
Journal:  Ann Vasc Dis       Date:  2014-12-25

Review 6.  Bio-Chemo-Mechanical Models of Vascular Mechanics.

Authors:  Jungsil Kim; Jessica E Wagenseil
Journal:  Ann Biomed Eng       Date:  2014-12-03       Impact factor: 3.934

7.  Inflammatory Cell Infiltrates in Acute and Chronic Thoracic Aortic Dissection.

Authors:  Darrell Wu; Justin C Choi; Aryan Sameri; Charles G Minard; Joseph S Coselli; Ying H Shen; Scott A LeMaire
Journal:  Aorta (Stamford)       Date:  2013-12-01

8.  Ascending Aortic Proaneurysmal Genetic Mutations with Antiatherogenic Effects.

Authors:  Alexander Curtis; Tanya Smith; Bulat A Ziganshin; John A Elefteriades
Journal:  Int J Angiol       Date:  2015-08-17

9.  Gender-dependent aortic remodelling in patients with bicuspid aortic valve-associated thoracic aortic aneurysm.

Authors:  Jiwon Lee; Mengcheng Shen; Nirmal Parajuli; Gavin Y Oudit; Michael Sean McMurtry; Zamaneh Kassiri
Journal:  J Mol Med (Berl)       Date:  2014-06-05       Impact factor: 4.599

Review 10.  Prospective and therapeutic screening value of non-coding RNA as biomarkers in cardiovascular disease.

Authors:  Albert Busch; Suzanne M Eken; Lars Maegdefessel
Journal:  Ann Transl Med       Date:  2016-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.